From THE HINDU group of publications
Sunday, January 07, 2001
|
From THE HINDU group of publications Sunday, January 07, 2001 |
||
|
|
        • SITE MAP • ARCHIVES • INDEX • HOME |
Bonds & FDs
| Previous
| Next
Parke-Davis India
Crisil has reaffirmed the `P1+' rating assigned to the Rs 26.8-crore commercial paper (CP) programme of Parke-Davis India Ltd (PDIL).
The continued high safety rating is based on the company's favourable business profile arising from its traditional over-the-counter (OTC) brands such as Gelusil and Benadryl and good brand recall. The launch of new products over the last few years has reduced its dependence on its mature brands. The global acquisition by Pfizer Inc of Warner-Lambert company Inc (WLC), the parent company of Parke-Davis, has led to the further strengthening of the parent company's leading position in the global pharmaceutical industry.
|
|
Section : Bonds & FDs Previous : Srei International Finance Next : Inflation rate remains static; WPI edges lower Stocks | Bonds & FDs | Mutual Funds | Industry | Markets | Personal Finance | Opinion | Indicators | Copyrights © 2001 The Hindu Business Line Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line |